
Rhone Capital buys ASK Chemicals
Rhone Capital has agreed to buy Germany-based ASK Chemicals, a joint venture between Clariant and Ashland.
ASK's enterprise value, before debt and assumed liabilities, stands at €257m. Total pre-tax returns amount to approximately €149m, split evenly between the two vendors under the terms of the 50/50 joint venture. Cash proceeds will total €128m, while €21m will be in the form of a buyer's note. ASK generated revenues of €513m in 2013.
The transaction is subject to regulatory approval, but is expected to complete during Q3 2014. The sale is part of a portfolio readjustment for both Clariant and Ashland, which are both looking to focus on their core businesses.
Company
Headquartered in Hilden, west Germany, ASK employs 1,800 people in 25 countries. The foundry chemicals manufacturer has a portfolio of resources, including binders, coatings, feeders, filters and release agents, as well as metallurgical products such as inoculants, inoculation wires and master alloys for iron casting.
The company was founded in 2010.
People
Hariolf Cottman is CEO of Clariant. James J O'Brien is chairman and CEO of Ashland. Stefan Sommer is CEO of ASK.
Advisers
Equity - White & Case, Ian Bagshaw (Legal).
Latest News
Stonehage Fleming raises USD 130m for largest fund to date, eyes 2024 programme
Multi-family office has seen strong appetite, with investor base growing since 2016 to more than 90 family offices, Meiping Yap told Unquote
Permira to take Ergomed private for GBP 703m
Sponsor deploys Permira VIII to ride new wave of take-privates; Blackstone commits GBP 200m in financing for UK-based CRO
Partners Group to release IMs for Civica sale in mid-September
Sponsor acquired the public software group in July 2017 via the same-year vintage Partners Group Global Value 2017
Change of mind: Sponsors take to de-listing their own assets
EQT and Cinven seen as bellweather for funds to reassess options for listed assets trading underwater